$16.790
+0.611 (+3.64%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
AVBP Prediction & Forecast by Similar Chart Analysis
Alphio's AVBP stock price prediction model matches the current ArriVent BioPharma, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $16.92 (+0.79%). The 1-week path is $16.41 (-2.29%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy ArriVent BioPharma, Inc. Stock?
Currently, Arrivent Biopharma Inc is not a good buy. The stock has seen a drastic decline of 40.82% over the last 5 days and 63% following a failed clinical trial, which has severely impacted investor confidence. The current price of $16.73 is significantly below the lowest analyst price target of $18, indicating a lack of immediate upside potential. The main risk is the ongoing negative sentiment due to trial failures, which has resulted in a staggering net income loss of $49.89 million in Q2 2026, highlighting the company's financial struggles.
AVBP stock price ended at $16.79 on Thursday, after rising +3.64%
ArriVent BioPharma, Inc. (AVBP) last closed at $16.79, gaining +3.64%. These facts feed the 1-day and 1-week AVBP price prediction above.
Forecast Drivers
ArriVent BioPharma, Inc. (AVBP) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches AVBP, ranked by similarity.
Seasonality analysis for AVBP
Historically the probability of a positive October return for AVBP is 44.83%. August offers the highest probability of a positive month at 67.19%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for AVBP
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $18.96 | $22.26 | $25.37 | +32.57% |
| Nov 2026 | $26.25 | $26.63 | $29.64 | +58.58% |
| Dec 2026 | $19.79 | $23.49 | $25.85 | +39.93% |
In 2026, ArriVent BioPharma, Inc. (AVBP) is projected to range from $18.96 to $29.64.
ArriVent BioPharma, Inc. 2026 monthly forecast
In Oct 2026, ArriVent BioPharma, Inc. is projected to average $22.26, with a low of $18.96 and high of $25.37.
In Nov 2026, ArriVent BioPharma, Inc. is projected to average $26.63, with a low of $26.25 and high of $29.64.
In Dec 2026, ArriVent BioPharma, Inc. is projected to average $23.49, with a low of $19.79 and high of $25.85.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.